Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-01

FDA Approved: NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE COLD AND SINUS — Original Application (VESPYR BRANDS LLC)

View source ↗

Summary

FDA approved Naproxen Sodium and Pseudoephedrine Hydrochloride Cold and Sinus as an Original Application for a new combination OTC product that relieves common …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naproxen Sodium and Pseudoephedrine Hydrochloride Cold and Sinus (Naproxen Sodium; Pseudoephedrine Hydrochloride)

Snippet

ORIG AP for NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE COLD AND SINUS (NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE)